Deals

Lilis Energy Raises $7.5M PIPE from Insiders at 15% Discount

By |

Lilis Energy, Inc. (LLEX) announced that it has raised $7,500,000 in a Units (Common Stock + Warrants) transaction. The common stock was sold at $2.00 per share, an approximate 15% discount to the market price ($2.35) of LLEX at deal announcement. A series of 3,750,000 42-Month Warrants with an exercise price of $2.50 per share (6.39% premium) was issued to the investors in this transaction. T.R. Winston & Company, Inc. acted as the exclusive agent on the transaction. The investors included members of the Company's Board of Directors and certain of its officers.

Deals

MagneGas Corp. Joins RDO with $2.1M Conv Preferred Issue to Alpha Capital Anstalt

By |

MagneGas Corporation (MNGA) announced that it has raised $2,141,133 in a Convertible Preferred Stock transaction. The fixed conversion price of the Convertible Preferred Stock is $0.80 per share, an approximate 27.93% discount to the market price ($1.11) of MNGA at deal announcement. A series of 2,676,416 60-Month Warrants with an exercise price of $1.11 per share (0% premium) was issued to the investor in this transaction. Northland Securities, Inc. acted as the exclusive agent on the transaction. The investor was Alpha Capital Anstalt. Placement Agent counsel was Faegre Baker Daniels LLP, issuer counsel was Szaferman Lakind Blumstein & Blader, PC, and investor counsel was Ellenoff Grossman & Schole LLP.

Deals

MagneGas Corp. Raises $1.9M at 28% Discount in RDO from Alpha Capital Anstalt

By |

MagneGas Corporation (MNGA) announced that it has raised $1,858,867 in a Registered Direct transaction. The common stock was sold at $0.80 per share, an approximate 28% discount to the market price ($1.11) of MNGA at deal announcement. Northland Securities, Inc. acted as the exclusive agent on the transaction. The investor was Alpha Capital Anstalt. Placement Agent counsel was Faegre Baker Daniels LLP, issuer counsel was Szaferman Lakind Blumstein & Blader, PC, and investor counsel was Ellenoff Grossman & Schole LLP. The transaction is expected to close by 01/27/2014.

Deals

OPKO Health Backs BioZone Pharmaceuticals in $2.75M EPP at 30% Discount

By |

BioZone Pharmaceuticals Incorporated (BZNE) announced that it has raised $2,750,000 in a Common Stock transaction. The common stock was sold at $0.50 per share, an approximate 30% discount to the market price ($0.71) of BZNE at deal announcement. A series of 5,500,000 120-Month Warrants with an exercise price of $0.50 per share (29.58% discount) was issued to the investors in this transaction. Palladium Capital Advisors acted as the exclusive agent on the transaction and the Investors include OPKO Health. Placement Agent counsel was Grushko & Mittman and issuer counsel was Nason Yeager Gerson White & Lioce.